Category: ACN Newswire

Everest Medicines Strengthens Its Cardiovascular Portfolio with CARDAMYST(R) Approved for the Conversion of Acute Symptomatic Episodes of PSVT to Sinus Rhythm in Adults in China

HONG KONG, Sept 3, 2026 – (ACN Newswire via SeaPRwire.com) – Everest Medicines today announced that China’s National Medical Products Administration (NMPA) has approved CARDAMYST(R) (etripamil) for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus

More

Xunce Technology Launches TokenCloud, Redefining the Value of Computing Power Through Full-Chain AI Infrastructure and Securing a Leading Position in the Token Economy Era

HONG KONG, Sept 3, 2026 – (ACN Newswire via SeaPRwire.com) – On September 3, Xunce Technology (3317.HK) officially launched the TokenCloud all-in-one AI model training and deployment computing power platform. As the hardware resources and infrastructure that facilitate the conversion

More